Skip to content
Study details
Enrolling now

Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

Wright State University
NCT IDNCT07116408ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

20

Study length

about 3 years

Ages

18+

Locations

1 site in OH

About this study

Researchers are testing whether a treatment that numbs the sphenopalatine ganglion, sprayed into the back of the nose, can reduce headache pain in people who have had bleeding from a brain aneurysm. This treatment aims to provide better pain relief without causing many side effects compared to standard medications. The trial will track how much pain medication patients need and their reported pain levels before and after receiving this new treatment.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Take Lidocaine (drug)
  • 2.Use Tx 360
PhasePhase 4
DrugLidocaine (drug)
Routetopical

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low9%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug classes

lidocaine

Drug routes

topical (Topical Cream)